Futura Medical plc
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a FUM.L research report →
Companywww.futuramedical.com
Futura Medical plc, a pharmaceutical company, develops pharmaceutical and healthcare products for the consumer healthcare markets focusing on sexual health and pain relief management. Its lead product is MED3000, a topical gel for the treatment of erectile dysfunction. The company also develops pain relief products, including TPR100, a topical diclofenac pain relief gel; CBD100, a topical cannabidiol formulation; and TIB200, a topical ibuprofen pain relief gel.
- CEO
- Alex Duggan
- IPO
- 2003
- Employees
- 14
- HQ
- Guildford, GB
Price Chart
Valuation
- Market Cap
- $2.13M
- P/E
- -0.45
- P/S
- 1.26
- P/B
- 1.44
- EV/EBITDA
- 0.14
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 65.89%
- Op Margin
- -554.63%
- Net Margin
- -534.62%
- ROE
- -310.00%
- ROIC
- -308.53%
Growth & Income
- Revenue
- $1.70M · -87.82%
- Net Income
- $-9,070,698 · -801.52%
- EPS
- $-0.03 · -746.51%
- Op Income
- $-8,966,067
- FCF YoY
- -332.80%
Performance & Tape
- 52W High
- $15.00
- 52W Low
- $0.60
- 50D MA
- $1.06
- 200D MA
- $2.64
- Beta
- 0.01
- Avg Volume
- 5.24M
Get TickerSpark's AI analysis on FUM.L
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our FUM.L Coverage
We haven't published any research on FUM.L yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate FUM.L Report →